Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
Date:7/28/2009

08, a record low for the Company.

As of June 30, 2009, $91.9 million, or 21.6%, of the Company's total debt of $426.4 million was subject to variable interest rates. The Company had total liquidity of $114.1 million, comprised of $76.4 million of cash and $37.7 million available under its revolving credit facility at June 30, 2009. On July 15, 2009 the Company repaid the $15.3 million outstanding balance on its revolving credit facility. The Company believes that it has sufficient liquidity to conduct its normal operations and fund its acquisition plan in 2009.

The Company is confirming its full year 2009 sales guidance of $750 to $760 million and is increasing its 2009 diluted EPS guidance by $0.06 to a range of $1.02 to $1.04.

"We are extremely pleased with our second quarter results as they exceeded our expectations and represent sound operational execution, particularly in this economic environment," commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group. Mr. Kirk added, "Our patient care centers growth of 4.4% continues to be a key driver of our revenues. Combined with our expense management efforts we have improved operating margins for the quarter by 70 basis points to 12.5% since the second quarter of last year. We move to the second half of the year in solid financial shape and focused on executing our business opportunities."

In June 2008, the Company's common stock performance triggered an acceleration of preferred stock dividends once the Company's average closing price of its common stock price exceeded the Company's forced conversion price of the Series A Convertible Preferred Stock by 200% for a 20-trading day period. This event accelerated the payment of Series A Convertible Preferred Stock dividends due from the time of the event through May 26, 2011. The accelerated dividends were paid in the form of increased stated value of p
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Receives Upgrade from Standard & Poors Rating Services
3. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
6. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
7. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
11. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., New York personal injur...e to have the number of a personal injury attorney...ands in a local Long Island backyard. , ...009 -- New York personal injury attorney David P...r that everyone should have the number of a person...
(Date:11/24/2009)..., Mercy Health System wil...ASIK surgery hosted by Robert Epstein, MD, board c...ery. Register today at www.MercyWebinars.com , ...-- Mercy Health System will present a live webinar...ccessed through an office or home computer and is ...
(Date:11/24/2009)...,, SOMERSET,N.J.,Nov.24/PRNewswire-FirstCall...fhealthcareandadministrativestaffingservices,today...tscommonstockfromTheNasdaqGlobalMarkettoTheNasdaqC...llbeeffectiveattheopeningofbusinessonWednesday,Nov...etotradeunderthesymbol"TSTF."TheNasdaqCapitalMarke...
(Date:11/24/2009)...,, MORRISVILLE,N.C.,Nov.24/PRNewswire/--TheA...einitialresultsofasurveyabouttheimpactofthe2010CMS...the1,200cardiologistsandcardiovascularultrasoundte...uldforcethemtostopacceptingMedicarepatients,reduce...reducingpatientaccesstoechocardiography(heartultra...
(Date:11/24/2009)... Exposure in infancy may lead to persistent wheezi...althDay News) -- Infants exposed to outdoor traffi...risk for asthma, researchers say. , Endotoxin -...mmune response in humans -- is found in dust. ,...archers found persistent wheezing (an early warnin...
Breaking Medicine News(10 mins):Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3Health News:Free LASIK Surgery Webinar 2Health News:Free LASIK Surgery Webinar 3Health News:Free LASIK Surgery Webinar 4Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 2Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 3Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2
...demand for Palliative care for treatment of chroni...vey of Hospitals, which has been reported in the J...s given to patients where chemotherapy or other tr...n demand for palliative care. Palliative care pr...
...ts in the US and Canada are looking to India to pr...sorders.// "Our consortium is trying to netwo...ent and devices in India," John Remmers, a pioneer... as the father of sleep medicine, and his associat...
...the in the January 15, 2006 issue of CANCER, the j...he prostate specific antigen (PSA) test is subject..., race, and diet. // This could lead to false p...A velocity, which is calculated as the rate of cha...
...he Communication in-charge of the Global Alliance ...ess conference in New Delhi, stated that The Globa...dollars.// Global Health Bonds are the first o... gross 3-4% interest. It is an opening for the...
...n are required for immunizing the most deprived ch...evyt of the Global Alliance for Vaccines and Immun...ired to be spent on vaccines alone. This will serv...s, 400 public health experts, and representatives ...
...Sunday five new suspected cases of avian flu in do...lta, where the deadly virus was first isolated in ... samples taken from dead poultry in a village of P...rds in more than a dozen villages in and around th...
Other Medicine News:Health News:Cheap Indian devices sought to treat sleep disorder 2Health News:Prostate Cancer Test Is Influenced By Age and Nutrition Factors 2Health News:More Funds Are Required For Immunisation Drive 2
(Date:11/24/2009)... MISSISSAUGA,Ontario,Nov.24/PRNewswire-FirstCall/-...developeroftechnologyandproductstargetingtheimmuno...ChimieS.A.S.("MerckChimie")isprogressingtothenextp...rysilvercoatedparamagneticBeads("Beads"). ,, Pe...thisyear,CardioGenicssuppliedMerckChimiewithitspro...
(Date:11/24/2009)... BEIJING,Nov.24/PRNewswire-Asia-FirstCall/--LotusP..."orthe"Company")agrowingdeveloperand,producerofpre...utical,productsinthePeople,sRepublicChina,todayrep...heBeijingpharmaceuticaldelegation. ,, Time:No...ionCenter,Chengdu ,, TheBeijingdelegationfeat...
(Date:11/24/2009)... WAYNE,N.J.,Nov.24/PRNewswire/--MAQUETCardiovascul...,announcedtodaythatithassignedaguaranteedtwo-yearc...rchasingorganizations,tobethesolesourceproviderofs... Underthetermsoftheagreement,whichrunsthroughOctob...oviderofbeatingheartdevicesanddisposablesuppliesto...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8
...Micromet, Inc. (Nasdaq: MITI ), a biopharmaceuti...es for the treatment of cancer, inflammation and a...tered into an agreement expanding its Committed Eq...pital Limited, a private investment group. Under ...ted to provide up to $75 million of capital during...
...eGen has announced that an oral,presentation of p...linical,trial of TG101348 in myeloproliferative di...ican Society of Hematology (ASH) Meeting. , , ...itle: A Phase I Study of TG101348, an...Selective Inhibitor, in Patients with, ...
Other Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6
FLEXILOG 2000 Pouch and Belt
pH Calibration Kit (pH1.07 and pH7.01)
13848 Buffer Solution pH 4.00 (250ml)
13847 Buffer Solution pH 1.07 (250ml)
Medicine Products: